Epion Therapeutics announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to ...

The AAOP's new training platform, developed with Alchemy Vision, enhances practice efficiency and patient care through ...

BVI's FineVision HP trifocal IOL, approved by the FDA, enhances the US premium IOL market with advanced optic design for multifocal vision correction. The lens features a diffractive optic design and ...

As part of Ophthalmology Times ’ 50th anniversary, this timeline highlights key technological advances in ophthalmology, beginning with breakthroughs in the 1970s that paved the way for decades of ...

The US Food and Drug Administration (FDA) has selected Abeona Therapeutics’ ABO-503 gene therapy for X-linked retinoschisis ...

Pediatric progressive myopia is a growing global public health concern, linked to serious ocular complications including ...

The Polaris platform is the world’s first AI-supported and robotics-enabled surgical system developed specifically for ...

REGENXBIO completed enrollment in its ATMOSPHERE and ASCENT trials that will be evaluating surabgene lomparvovec (sura-vec, ...

Early and aggressive treatment of dry eye disease can prevent progression and preserve ocular health, especially in glaucoma ...

Considering this knowledge of the retina, the investigators conducted a study in which the goals were to detect and quantify ...

The US Food and Drug Administration (FDA) has approved Celltrion’s aflibercept-boav (EYDENZELT) biosimilar referencing ...

The jump from training to independent practice is a uniquely personal experience. For some, it feels like a natural next step ...